Printer Friendly

HTG Announces Availability of 96 Max Gene Expression Assay at American Association of Cancer Research (AACR) Annual Meeting.

DENVER -- HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA[TM]) today announced the launch of the quantitative Nuclease protection assay (qNPA[TM]) 96 Max gene expression assay at the American Association of Cancer Research (AACR) annual meeting. This new testing configuration enables the measurement of 46 genes in a 96 well Array Plate. The offering provides researchers with the ability to analyze a larger number of gene signatures for research and clinical validation work in academic and translational medicine.

This 96 Max gene expression automated assay is based on HTG's proven qNPA ArrayPlate technology platform, which allows researchers to investigate a larger set of genes with greater precision than traditional gene expression assays. The technology allows academic researchers to quickly and efficiently measure gene expression levels of mRNA and miRNA in a variety of cell and tissue types including formalin-fixed, paraffin-embedded (FFPE) samples. The technology is ideal for detecting small, yet important changes in gene expression levels which other gene expression platforms cannot reliably detect.

"HTG's new assay offering enables our academic researchers, who are conducting clinical and basic research, to essentially unlock information from sample types that were previously very challenging and near impossible to evaluate accurately," said BJ Kerns, VP Strategic Marketing and Business Development, HTG. "This is yet another expansion of our ArrayPlate platform. We devised this unique testing format to accommodate the needs of academic researchers who are evaluating tumor stratification, pathway and outcome schemes, as well as chemosensitivity."

About HTG

Privately-held HTG is based in Tucson, Arizona. Investors in the company include Solstice Capital, Valley Ventures, Merck Capital Ventures, Village Ventures and Arcturus Capital. Additional information is available at www.htgenomics.com.
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 20, 2009
Words:279
Previous Article:Mavent, QuestSoft Alliance Helps Lenders Meet Secondary Market Demands.
Next Article:Carl Lamm Holding AB: New Date for Interim Report Regarding Q3, January-March 2009.
Topics:

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters